Tags

Type your tag names separated by a space and hit enter

Insulin resistance in patients with polycystic ovary syndrome.
Ann Med 2004; 36(6):426-39AM

Abstract

With a prevalence of 5%-10% the polycystic ovary syndrome (PCOS) is an exceptionally common disorder of premenopausal women. According to prospective studies, women with PCOS present abnormal glucose tolerance and diabetes mellitus in 31%-35% and 7.5%-10%, respectively. PCOS patients have a higher prevalence of cardiovascular risk factors such as hypertension, type 2 diabetes and dyslipidaemia. The rate of spontaneous abortions as well as the risk to develop gestational or type 2 diabetes is increased in PCOS. Therefore, PCOS is not only a reproductive problem but a complex endocrine disease with important health implications. The role of the glucose metabolism in PCOS, the health consequences and possible interventions are reviewed in this article.

Authors+Show Affiliations

Department of Gynaecology and Obstetrics, University of Schleswig-Holstein, Campus Luebeck, Germany.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

15513294

Citation

Schröder, Annika K., et al. "Insulin Resistance in Patients With Polycystic Ovary Syndrome." Annals of Medicine, vol. 36, no. 6, 2004, pp. 426-39.
Schröder AK, Tauchert S, Ortmann O, et al. Insulin resistance in patients with polycystic ovary syndrome. Ann Med. 2004;36(6):426-39.
Schröder, A. K., Tauchert, S., Ortmann, O., Diedrich, K., & Weiss, J. M. (2004). Insulin resistance in patients with polycystic ovary syndrome. Annals of Medicine, 36(6), pp. 426-39.
Schröder AK, et al. Insulin Resistance in Patients With Polycystic Ovary Syndrome. Ann Med. 2004;36(6):426-39. PubMed PMID: 15513294.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Insulin resistance in patients with polycystic ovary syndrome. AU - Schröder,Annika K, AU - Tauchert,Sascha, AU - Ortmann,Olaf, AU - Diedrich,Klaus, AU - Weiss,Jürgen M, PY - 2004/10/30/pubmed PY - 2005/2/26/medline PY - 2004/10/30/entrez SP - 426 EP - 39 JF - Annals of medicine JO - Ann. Med. VL - 36 IS - 6 N2 - With a prevalence of 5%-10% the polycystic ovary syndrome (PCOS) is an exceptionally common disorder of premenopausal women. According to prospective studies, women with PCOS present abnormal glucose tolerance and diabetes mellitus in 31%-35% and 7.5%-10%, respectively. PCOS patients have a higher prevalence of cardiovascular risk factors such as hypertension, type 2 diabetes and dyslipidaemia. The rate of spontaneous abortions as well as the risk to develop gestational or type 2 diabetes is increased in PCOS. Therefore, PCOS is not only a reproductive problem but a complex endocrine disease with important health implications. The role of the glucose metabolism in PCOS, the health consequences and possible interventions are reviewed in this article. SN - 0785-3890 UR - https://www.unboundmedicine.com/medline/citation/15513294/Insulin_resistance_in_patients_with_polycystic_ovary_syndrome_ L2 - http://www.tandfonline.com/doi/full/10.1080/07853890410035296 DB - PRIME DP - Unbound Medicine ER -